ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,160, issued on Sept. 9, was assigned to Gilead Sciences Inc. (Foster City, Calif.).
"KHK inhibitors" was invented by James L. Bachman (Seattle), Daniel H. Byun (Foster City, Calif.), Christopher T. Clark (Seattle), Petr Jansa (Foster City, Calif.), Joshua A. Kaplan (Foster City, Calif.), Zachary A. Kasun (Seattle), Jennifer R. Lo (Seattle), Megan E. Neubig (San Diego), Nathaniel H. Stanley (San Francisco) and Kirk L. Stevens (Bothell, Wash.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds of formula:wherein the variable substituents are defined herein."
The patent was filed on March 25, 2022, under Application No. 17/704,440.
*For further...